SUMATRIPTAN AND NAPROXEN SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Sumatriptan And Naproxen Sodium patents expire, and what generic alternatives are available?
Sumatriptan And Naproxen Sodium is a drug marketed by Aurobindo Pharma Ltd, Rising, and Sun Pharm. and is included in three NDAs.
The generic ingredient in SUMATRIPTAN AND NAPROXEN SODIUM is naproxen sodium; sumatriptan succinate. There are forty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the naproxen sodium; sumatriptan succinate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SUMATRIPTAN AND NAPROXEN SODIUM?
- What are the global sales for SUMATRIPTAN AND NAPROXEN SODIUM?
- What is Average Wholesale Price for SUMATRIPTAN AND NAPROXEN SODIUM?
Summary for SUMATRIPTAN AND NAPROXEN SODIUM
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 3 |
| Clinical Trials: | 25 |
| DailyMed Link: | SUMATRIPTAN AND NAPROXEN SODIUM at DailyMed |
Recent Clinical Trials for SUMATRIPTAN AND NAPROXEN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Second Affiliated Hospital of Kunming Medical University | Phase 3 |
| Second Hospital of Jilin University | Phase 3 |
| Beijing Friendship Hospital | Phase 3 |
Pharmacology for SUMATRIPTAN AND NAPROXEN SODIUM
US Patents and Regulatory Information for SUMATRIPTAN AND NAPROXEN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | SUMATRIPTAN AND NAPROXEN SODIUM | naproxen sodium; sumatriptan succinate | TABLET;ORAL | 207457-001 | Feb 15, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | SUMATRIPTAN AND NAPROXEN SODIUM | naproxen sodium; sumatriptan succinate | TABLET;ORAL | 090872-001 | Sep 4, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm | SUMATRIPTAN AND NAPROXEN SODIUM | naproxen sodium; sumatriptan succinate | TABLET;ORAL | 202803-001 | Jul 20, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
